Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Atria’s financial reporting in 2019

Atria Plc, Company announcement, 22 August 2018 at 4 pmAtria’s financial reporting in 2019The 2018 Financial Statement Release of Atria Plc will be published on February 13, 2019 at 8:00 am. The Annual General Meeting will be held in Helsinki on April 26, 2019. By virtue of the Limited Liability Companies Act, a shareholder has the right to put matters that fall within the competence of the General Meeting on the agenda of the General Meeting, provided the shareholder makes a written request to the Board of Directors in time for the matter to be included in the notice of meeting. The

#18-1482 Listing of Turbo warrant issued by Commerzbank AG

As from August 23, 2018, 1 Turbo warrant issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Call Turbo warrant of European type Execution: Automatic cash settlement Term: As from August 23, 2018 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se

Conversion of Yorkville’s convertible notes into shares

The Board of Directors of Panion Animal Health AB (the “Company” or “Panion”) has, pursuant to the terms and conditions of the financing arrangement between Panion and an investment fund managed by Yorkville Advisors Global (“Yorkville”) announced on 9 January 2018, resolved to approve the request of Yorkville to convert a proportion of SEK 300,000 of the convertible notes to shares in the Company at conversion price of SEK 1.04 per share. The conversion shall be executed by issuing a total of 288,461 shares to Yorkville. With the transfer included a total of SEK 2,500,000 of the

Konecranes wins large repeat order for container cranes in Lithuania

Konecranes wins large repeat order for container cranes in LithuaniaJSSC Klaipedos Smelte in the Port of Klaipeda, Lithuania, has placed a large repeat order with Konecranes for ten Rubber Tired Gantry (RTG) cranes and two Ship-to-Shore (STS) cranes. The delivery of the RTG cranes will be completed in November 2019 and the STS cranes in December 2019. The parties have agreed not to disclose the value of the order.In August 2018 Konecranes signed a contract with JSSC Klaipedos Smelte in the Port of Klaipeda, Lithuania, for the supply of ten Konecranes RTG cranes and two Konecranes STS

Nel ASA: Constructing the world’s largest electrolyzer manufacturing plant

(Oslo, 22 August 2018) Nel ASA (“Nel”) today announces the construction of the world’s largest electrolyzer plant, fully automated and able to deliver the most efficient electrolyzers at a game changing cost. The total development will have a name plate capacity of 360 MW/year, approximately ten times the current annual production capacity, and the new facility will accommodate the multi-billion NOK order from Nikola Motor Company (Nikola). The manufacturing plant will be constructed as an extension of the current facility at Notodden, Norway, with total planned investments of around NOK

4Subsea Awarded Master Service Agreement for Well Monitoring and Data Processing with Equinor

4Subsea has been awarded a 3-year Master Service Agreement for processing of BOP measurement data for a selection of Equinor’s mobile drilling units operating on subsea wells.Asker, August 22nd 2018 – The purpose of the contract with Equinor is to provide well monitoring services and rental of sensors to support Equinor’s need for collecting, processing, and documenting BOP measurement data for improved operational decision support. “Equinor is in the forefront of the industry in the way they are applying data and digital services to reduce operational risk and cost during drilling

I.A. Hedin Bil has closed the deal to acquire five additional Mercedes-Benz dealerships in Belgium

After approval from the Belgian Competition Authorities, the acquisition of five Mercedes-Benz dealerships around Antwerp was finalized. This means that Hedin Bil, through the brand Hedin Automotive, is present at twelve locations in Belgium.Gothenburg, August 22, 2018 In the beginning of April 2018, it was announced that I.A. Hedin Bil had through its subsidiary, Hedin Belgien Bil AB, entered an agreement with the Belgian company Andries NV to acquire its subsidiaries Eddy Joosen NV, Garage A. Swinnen BVBA, Garage Euromotors NV and Garage Vriesdonk NV.The transaction, which was

Leading Edge Materials Reports Spheronising Test Results from Woxna Graphite Project, Sweden

VANCOUVER, BC, August 22, 2018 /CNW/ - Leading Edge Materials Corp. (“Leading Edge Materials”) or (“the “Company”) (TSXV:LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) is pleased to provide the latest results from spheronisation test work undertaken on graphite from the Woxna graphite mine in Sweden. Woxna is a fully constructed mine, with all processing, waste management and infrastructure in place. During 2017, Woxna was granted an extension to its operating license until 2041. As previously disclosed (5th July 2018), Leading Edge Materials is undertaking various research and

Breakthrough in autoimmune testing – IMMrayTM based novel biomarker signature identifies patients with anti-CCP negative rheumatoid arthritis

LUND, Sweden ― Immunovia today announced that a new study confirms that the IMMray™ blood test successfully addresses one of the major challenges in autoimmune testing. The present study, performed in collaboration with Linköping University, showed that IMMray™ technology can identify patients with rheumatoid arthritis (RA), despite testing negative with antibodies against cyclic citrullinated peptides (CCP). Currently, this important group of patients – representing 25-30% of all RA cases – is missed using the present gold standard assay to analyze IgG-class anti-CCP.The present study

Interim Report January – June 2018

Significant events during the second quarter 2018 · Golder was contracted for the finalisation of the feasibility study for Blötberget. · The studies regarding mine design and production planning was reported · The formerly long-term loan was replaced in equal amounts by a directed issue of shares and a convertible loan with a two year maturity. · A rights issue amounting to MSEK 36.5 was decided upon and started. Second quarter, 1 April – 30 June 2018 · Income amounted to SEK 0 million (0) · Earnings after tax amounted to SEK –2.6 million (–2.6) · Investments in

MMT signs 10 new contracts

MMT has during the past two months received 10 new subsea survey and inspection projects within the offshore wind, renewable energy and oil and gas industry.MMT is proud to present a wide profolio of old and new clients such as Siccar Point Energy, Equinor, Perenco, SSE, Örsted, Vattenfall, GreenLink Interconnector, National Grid, Wintershall and BP Trinidad. Working for these companies confirms MMT’s capabilities of being a qualified provider of services ranging from traditional geophysical surveys to UXO inspection and excavation, 2d seismic and ROV inspections. Some of the

Interim report April - June 2018

CEO’s comments The first quarter's sales corresponds to our expected growth as communicated in the year-end report. The gross margin continues to exceed 50%. As we previously announced, the company will start applying a much more restrictive accounting policy for development costs, starting this quarter. The effect of this on the bottom line is in the order of -10 MSEK for the full year.   We continue to receive new MAAs and expand our portfolio. In the first quarter, Prednisolone EQL Pharma and Acetazolamide EQL Pharma were approved for sale by the Swedish Medical Products Agency (MPA).

Company Announcement No. 81, 2018 - Results of the auction of covered mortgage bonds in Nordea Kredit Realkreditaktieselskab

Nordea Kredit Realkreditaktieselskab has auctioned covered mortgage bonds to refinance ARMs as per 1 October 2018 on 21 August and 22 August 2018. The auction results are presented in the table in the pdf-file.Questions regarding the auctions may be directed to Nordea, Long Term Funding, Peter Brag at +45 33 33 16 63 or Finn Nicolaisen at +45 33 33 16 25. Yours faithfullyNordea Kredit Realkreditaktieselskab

Sedana Medical to host conference call to provide second quarter 2018 business update

On August 30, 2018, at 07:00 am CET, Sedana Medical AB (publ) (Sedana Medical or the Company) will publish its interim report for the second quarter 2018. All interested parties are invited to participate in a web-cast telephone conference, which will include a presentation, on the same day at 09:30 am CET. The event will be hosted by Sedana Medical's CEO Christer Ahlberg and CMO Peter Sackey. The presentation will be held in English.How to participate: The live webcast and a recorded on-demand version including the presentation material will be accessible at:  https://tv.

First patient treated with CE-marked Elekta Unity at University Medical Center Utrecht

Milestone heralds the age of personalized and precision radiation medicine for cancer patients in EuropeUTRECHT, The Netherlands, August 22, 2018 – Elekta (EKTA-B.ST) today announced that the University Medical Center (UMC) Utrecht has started treating cancer patients using a CE-marked, fully-integrated clinical radiation treatment workflow on the company’s high-field magnetic resonance radiation therapy (MR/RT) system, Elekta Unity. “Elekta Unity represents a new paradigm of precision radiotherapy that enables a scan-plan-treat approach, and supports personalized regimens that meet the

Sobi™ appoints Anne Marie de Jonge Schuermans as Head of Technical Operations

Swedish Orphan Biovitrum AB (publ) (Sobi™)  has appointed Anne Marie de Jonge Schuermans as Head of Sobi’s new Technical Operations organisation, bringing together Sobi’s Manufacturing Operations/Biological Development & Supply, Quality, Supply Chain, Procurement and Environment & Safety operations. Anne Marie will join on 1 October 2018, and be part of Sobi’s Executive Committee. Anne Marie joins Sobi from Biogen where she served as Vice President for Global Supply Chain Operations & Strategic Partnerships and as an Executive Board Member of Biogen International

2cureX strengthen its patent portfolio with the granting of a new European patent

2cureX AB (“2cureX”) is pleased to announce the grant of European patent No. 3164709 “Identifying compounds modifying a cellular phenotype”. The patent protects the use of patient-derived micro-tumors for cancer treatment design. Together with 2cureX’s existing patent portfolio the patent provides a broad protection of the company’s IndiTreat technology in its European launch markets. The patent is valid until July 2035. The patent is currently also being prosecuted in territories outside Europe (e.g. USA).The IndiTreat technology generates thousands of small micro-tumors (tumoroids) from a

Changes to Pihlajalinna Plc’s Management Team

Pihlajalinna Plc                   Stock exchange release                        22 August 2018 at 13:00 Changes to Pihlajalinna Plc’s Management Team Stefan Wentjärvi has been appointed as Pihlajalinna’s Head of Sales. He will start in the position and also as member of the Group Management Team on 1 September 2018. Wentjärvi has acted as the CEO of Doctagon since 2014. Doctagon has been part of the Pihlajalinna Group since March 2018. In addition, he acted as the managing director of Blue 1 in 2005–2012 and CFO in 2000–2005. Wentjärvi holds a Master of Social Sciences degree. ”

Interim Report January – June 2018

· Order intake was 2,959.2 (2,700.4) MSEK, which is an overall growth of 9.6%, adjusted to 0.4 % for acquisitions of 194.8 MSEK and currency effects of 54.2 MSEK  · Net sales were 2,692.3 (2,544.7) MSEK, which is an overall growth of 5.8%, adjusted to -3.2% for acquisitions of 179.6 MSEK and currency effects of 49.3 MSEK  · Operating profit was 305.2 (313.3) MSEK, representing a 2.6% decrease with an operating margin of 11.3 (12.3)% · Earnings after tax were 213.9 (216.5) MSEK, a decrease of 1.2% · Earnings per share were 1.87 (1.90) SEK  · Cash flow from operating activities

Fortune Names ABB among Top 10 Companies in “Change the World” List

Zurich, Switzerland, August 22, 2018 - ABB’s global leadership in fast charging solutions for electric vehicles leads Fortune magazine to rank it #8 among top companies that “help the planet and tackle social problems.”ABB has been named #8 in Fortune magazine’s “Change the World ” rankings for the company’s efforts to speed up adoption of clean-energy electric transportation. The list, Fortune said, honors companies that “have had a positive social impact through activities that are part of their core business strategy.” In naming ABB 

There are no items matching the current filter
There are no more items matching the current filter
Back to top